# FDA Inspection 1302098 - Omnia Biologix, LLC - February 04, 2026

Source: https://www.keypedia.com/records/fda_inspections/omnia-biologix-llc/8dfa6bea-c276-4d3b-98b2-c6bdcf07a47e
Source feed: FDA_Inspections

> FDA Inspection 1302098 for Omnia Biologix, LLC on February 04, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302098
- Company Name: Omnia Biologix, LLC
- Inspection Date: 2026-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1302098 - 2026-02-04](https://www.keypedia.com/records/fda_inspections/omnia-biologix-llc/0b437c49-f14e-4b6e-9d7f-c76a4a6d18fc)
- [FDA Inspection 1195138 - 2023-01-04](https://www.keypedia.com/records/fda_inspections/omnia-biologix-llc/350ba952-4eb5-4eec-9b68-d2f657548c09)
- [FDA Inspection 1195138 - 2023-01-04](https://www.keypedia.com/records/fda_inspections/omnia-biologix-llc/185c69f0-2c02-4993-9447-a7457b7a1692)
- [FDA Inspection 1195138 - 2023-01-04](https://www.keypedia.com/records/fda_inspections/omnia-biologix-llc/aecd9c6d-b31a-4f60-9cd0-add6c3aac045)
- [FDA Inspection 1063135 - 2018-07-10](https://www.keypedia.com/records/fda_inspections/omnia-biologix-llc/7a5f3aa4-8cd6-4bb6-87f9-b70751b9ed90)

Company: https://www.keypedia.com/companies/omnia-biologix-llc/7d7569ca-0d21-48cd-ac98-5a4ff2fc61b5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d